Personal information
No personal information available
Biography
Dr. Shi Ming has sufficient experience in liver cancer treatment including locoregional and systemic therapy, like surgery, interventional therapy, target therapy and immunotherapy. He has done a lot of clinical trials and fundamental research focus on optimizing the treatment of stages of B&C HCC. He has numerous publications as corresponding author in the J Clin Oncol, JAMA Oncol, J Natl Cancer Inst, Hepatology, and more. He also figured out that arterial chemotherapy is the critical factor to improve the TACE effect, and proposed a new scheme of hepatic arterial infusion chemotherapy of FOLFOX (FOLFOX-HAIC). Furthermore, he has proposed a new treatment strategy: triple combined therapy (FOLFOX-HAIC + target therapy + immunotherapy) for advanced hepatocellular carcinoma. Additionally, he has done much research to figure out novel biomarkers predicting drug resistance, and discovered a novel therapeutic target of hepatocellular carcinoma. The above research projects have been cited by six international guidelines and consensuses, including the 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights, Guidelines of Chinese society OF clinical oncology (CSCO): Hepatocellular carcinoma, Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO, EASL–EORTC Clinical Practice Guidelines: Management (2012), and Guidelines of the American Society for Interventional Radiology for Liver Cancer (2012).
Activities
Employment (1)
Education and qualifications (2)
Professional activities (2)
Funding (1)
No.82072610
Works (50 of 52)
10.1016/j.ejca.2013.11.026
24332572
10.1007/s12032-013-0696-3
23975633
10.1158/1078-0432.CCR-12-2728
23812667
10.1111/liv.12112
23402625
10.1093/jnci/djt046
23724419
10.1093/jnci/djs464
23150720
10.1371/journal.pone.0060444
23565248
PMC3614950
24083739
10.1016/j.jhep.2012.03.027
22521360
10.1148/radiol.11110817
22357902
10.1371/journal.pone.0044061
22952874
PMC3432106
10.1186/1479-5876-10-245
23228017
PMC3552726
10.1111/j.1872-034X.2011.00796.x
21615643
10.1016/j.jvir.2010.12.041
21514523
10.1111/j.1440-1746.2010.06511.x
21488945
10.1148/radiol.10101072
21330557
10.1245/s10434-010-1321-8
20839057
10.3748/wjg.v16.i16.2046
20419844
PMC2860084
10.3748/wjg.v16.i2.264
20066748
PMC2806567
10.1007/s12072-010-9192-4
21063476
PMC2940006
19895743
10.1007/s00432-009-0588-2
19408012
10.1016/j.humpath.2008.08.011
18992916
18423125
18334126
18184471
10.1097/01.sla.0000231758.07868.71
17197963
17359695
17094918
17059766
10.1007/s00432-006-0097-5
16763805
16831281
16687082
16875630
16737621
16004798
16004810